Anti-NGF ADCC Enhanced Antibody (PG110) is an ADCC enhanced antibody produced by our Afuco™ platform. PG110 is a monoclonal antibody that inhibits the effects of the naturally occurring substance, nerve growth factor (NGF). Phase I study to evaluate the safety, tolerability, and pharmacokinetics of PG110 (Anti-NGF Monoclonal Antibody) in patients with pain attributed to osteoarthritis of the knee.
This is a product of Creative Biolabs' Hi-Affi™ recombinant antibody portfolio, which has several benefits including:
• Increased sensitivity
• Confirmed specificity
• High repeatability
• Excellent batch-to-batch consistency
• Sustainable supply
• Animal-free production
See more details about Hi-Affi™ recombinant antibody benefits.
Download resources about recombinant antibody development and antibody engineering to boost your research.
Select a product category from the dropdown menu below to view related products.
CAT | Product Name | Application | Type |
---|---|---|---|
DrMAB-146 | Recombinant Rat Anti-Ngf Antibody, clone αD11 | IF, ELISA | IgG |
PABL-285 | Human Anti-NGF Recombinant Antibody (clone CNTO7309) | WB, ELISA, IF, FuncS | Human IgG |
PABL-286 | Human Anti-NGF Recombinant Antibody (clone mab 911) | WB, ELISA, FuncS | Human IgG |
MOB-1332MZ | Recombinant Mouse Anti-Human NGF Antibody (clone BT32) | ELISA, Neut, sELISA | Mouse antibody |
MRO-2073-CN | Rabbit Anti-NGF Polyclonal Antibody (MRO-2073-CN) | WB, IF, IHC | Rabbit IgG |
There are currently no Customer reviews or questions for AFC-659CL. Click the button above to contact us or submit your feedback about this product.
For Research Use Only. Not For Clinical Use.
For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.